Literature DB >> 31330360

Neural stem cell dynamics: the development of brain tumours.

Anna E Hakes1, Andrea H Brand2.   

Abstract

Determining the premalignant lesions that develop into malignant tumours remains a daunting task. Brain tumours are frequently characterised by a block in differentiation, implying that normal developmental pathways become hijacked during tumourigenesis. However, the heterogeneity of stem cells and their progenitors in the brain suggests there are many potential routes to tumour initiation. Studies in Drosophila melanogaster have enhanced our understanding of the tumourigenic potential of distinct cell types in the brain. Here we review recent studies that have improved our knowledge of neural stem cell behaviour during development and in brain tumour models.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31330360     DOI: 10.1016/j.ceb.2019.06.001

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  9 in total

1.  Homeodomain protein Six4 prevents the generation of supernumerary Drosophila type II neuroblasts and premature differentiation of intermediate neural progenitors.

Authors:  Rui Chen; Yanjun Hou; Marisa Connell; Sijun Zhu
Journal:  PLoS Genet       Date:  2021-02-08       Impact factor: 5.917

2.  Regulation of developmental hierarchy in Drosophila neural stem cell tumors by COMPASS and Polycomb complexes.

Authors:  Cassandra Gaultier; Sophie Foppolo; Cédric Maurange
Journal:  Sci Adv       Date:  2022-05-11       Impact factor: 14.957

3.  Neural stem cell temporal patterning and brain tumour growth rely on oxidative phosphorylation.

Authors:  Jelle van den Ameele; Andrea H Brand
Journal:  Elife       Date:  2019-09-12       Impact factor: 8.140

4.  Tailless/TLX reverts intermediate neural progenitors to stem cells driving tumourigenesis via repression of asense/ASCL1.

Authors:  Anna E Hakes; Andrea H Brand
Journal:  Elife       Date:  2020-02-19       Impact factor: 8.140

Review 5.  Trends and challenges in modeling glioma using 3D human brain organoids.

Authors:  Aruljothi Mariappan; Gladiola Goranci-Buzhala; Lucia Ricci-Vitiani; Roberto Pallini; Jay Gopalakrishnan
Journal:  Cell Death Differ       Date:  2020-12-01       Impact factor: 15.828

Review 6.  Opportunities and challenges of glioma organoids.

Authors:  Xiangdong Xu; Lingfei Li; Linting Luo; Lingling Shu; Xiaoli Si; Zhenzhen Chen; Wenqing Xia; Jinyu Huang; Yang Liu; Anwen Shao; Yiquan Ke
Journal:  Cell Commun Signal       Date:  2021-10-11       Impact factor: 5.712

7.  Intra-cerebellar schwannoma with various degenerative changes: a case report and a systematic review.

Authors:  Yasuhide Takeuchi; Yoshiki Arakawa; Hideaki Yokoo; Yoshiki Mikami; Yukinori Terada; Kazumichi Yoshida; Susumu Miyamoto; Hironori Haga
Journal:  BMC Neurol       Date:  2022-02-24       Impact factor: 2.474

8.  Reduced chromatin accessibility correlates with resistance to Notch activation.

Authors:  Jelle van den Ameele; Robert Krautz; Seth W Cheetham; Alex P A Donovan; Oriol Llorà-Batlle; Rebecca Yakob; Andrea H Brand
Journal:  Nat Commun       Date:  2022-04-25       Impact factor: 17.694

9.  Optimal Preclinical Conditions for Using Adult Human Multipotent Neural Cells in the Treatment of Spinal Cord Injury.

Authors:  Jeong-Seob Won; Je Young Yeon; Hee-Jang Pyeon; Yu-Jeong Noh; Ji-Yoon Hwang; Chung Kwon Kim; Hyun Nam; Kyung-Hoon Lee; Sun-Ho Lee; Kyeung Min Joo
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.